HC Wainwright Has Negative Forecast for DRUG Q3 Earnings
Bright Minds Biosciences Inc. (NASDAQ:DRUG – Free Report) – Stock analysts at HC Wainwright reduced their Q3 2025 earnings estimates for shares of Bright Minds Biosciences in a research note issued on Thursday, May 22nd. HC Wainwright analyst P. Trucchio now expects that the company will earn ($0.76) per share for the quarter, down from […]
